Related Experiment Video
Updated: Aug 22, 2025

Inducing and Characterizing Vesicular Steatosis in Differentiated HepaRG Cells
Published on: July 18, 2019
The HSF1-CPT1a Pathway Is Differentially Regulated in NAFLD Progression
Wiebke Breternitz1, Friedrich Sandkühler1, Frauke Grohmann1
1Laboratory of Molecular Gastroenterology & Hepatology, Department of Internal Medicine I, UKSH-Campus Kiel, 24105 Kiel, Germany.
Heat shock factor 1 (HSF1) plays a key role in non-alcoholic fatty liver disease (NAFLD) pathogenesis. Targeting HSF1 activation may offer a novel therapeutic strategy for managing NAFLD and obesity-associated liver conditions.
Area of Science:
- Hepatology
- Molecular Biology
- Metabolic Diseases
Background:
- Obesity-associated diseases, particularly non-alcoholic fatty liver disease (NAFLD), represent a significant global health challenge.
- Aberrant hepatic lipid accumulation is a hallmark of NAFLD pathogenesis.
- Bariatric surgery demonstrates efficacy in NAFLD, suggesting underlying molecular mechanisms related to liver remodeling.
Purpose of the Study:
- To investigate the role of heat shock factor 1 (HSF1) in the pathogenesis of NAFLD.
- To elucidate the molecular pathways modulated by HSF1 in hepatic lipid metabolism.
- To explore potential therapeutic strategies targeting HSF1 for NAFLD treatment.
Main Methods:
- Comparative analysis of methylation signatures in liver biopsies before and after bariatric surgery.
- Utilizing cellular models of NAFLD to study HSF1 activation during hepatocyte fat accumulation.
- Promoter analysis and HSF1 knockdown experiments to identify HSF1 target genes.
- Pharmacological activation of HSF1 using celastrol.
Main Results:
- Significantly enriched HSF1 binding sites in liver remodeling post-bariatric surgery.
- HSF1 activation observed in hepatocytes with fat accumulation, mimicking pre-bariatric surgery conditions.
- Carnitine palmitoyltransferase 1 isoform A (CPT1a) identified as a HSF1 target gene, regulating lipid beta-oxidation.
- Pharmacological HSF1 activation with celastrol reduced hepatic fat accumulation in a HSF1-dependent manner.
Conclusions:
- HSF1 activity is critically relevant to NAFLD pathogenesis.
- A functional pathway involving HSF1 and CPT1a in regulating hepatic lipid metabolism has been identified.
- Targeting HSF1 activation presents a promising therapeutic avenue for NAFLD.
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Pathophysiology of Heart Failure
Regulation of Angiogenesis and Blood Supply
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Regulation of Nuclear Protein Sorting

